There is an error in Table 3. The information in the Reference column in rows 15–18 is incorrect. Please see the correct Table 3 here.
| Value | Description | Reference |
|---|---|---|
| 21.0% | 30-Day readmission rate for the overall patient cohort in a 3-month timeframe preceding ICP implementation (Pre-ICP) | Alabama Integrated Care Program. 2016–2018 |
| 61.0% | 31–90 Day hospitalization rate for the overall patient cohort in a 3-month timeframe preceding ICP implementation (Pre-ICP) | Alabama Integrated Care Program. 2016–2018 |
| 16.0% | 30-Day readmission rate in a 3-month timeframe preceding ICP implementation for a patient cohort who enrolled in ICP that were not prescribed NIV (ICP) | Alabama Integrated Care Program. 2016–2018 |
| 11.0% | 30-Day readmission rate for an ICP patient cohort after ICP implementation | Alabama Integrated Care Program. 2016–2018 |
| 111.4% | 31–90 Day hospitalization rate in a 3-month timeframe preceding ICP implementation for a patient cohort who enrolled in ICP that were not prescribed NIV (ICP) | Alabama Integrated Care Program. 2016–2018 |
| 0.0% | 30-Day readmission rate in a 3-month timeframe preceding ICP implementation for a patient cohort who enrolled in ICP that were prescribed NIV (ICP + NIV) | Alabama Integrated Care Program. 2016–2018 |
| 6.3% | 30-Day readmission rate for an ICP + NIV patient cohort after ICP implementation | Alabama Integrated Care Program. 2016–2018 |
| 100.0% | 31–90 Day hospitalization rate in a 3-month timeframe preceding ICP implementation for a patient cohort who enrolled in ICP that were prescribed NIV (ICP + NIV) | Alabama Integrated Care Program. 2016–2018 |
| 9.1% | 31–90 Day hospitalization rate for an ICP + NIV patient cohort after ICP implementation | Alabama Integrated Care Program. 2016–2018 |
| 10.2% | Mortality rate of all patients after enrolling in the ICP | Alabama Integrated Care Program. 2016–2018 |
| $6,971 | CMS Reimbursement to a US hospital for a patient admission (excluding 0-30-day readmissions) | CMS "Medicare charge in-patient summary" for DRG 190 with MCC FY2016 within national summary FY2016 (Updated August 2018) |
| $1,057 | CMS Reimbursement to home medical equipment provider (HME) for NIV (AVAPS-AE (Trilogy 100)) device, supplies and supportive care (per month) | 2019 CMS Average. CPT code E0465, E0466 |
| $11,400 | Cost per Readmission (within 30-days of initial admission) | American Hospital Network, 2016 Assume ~8% yearly increase |
| $10,862 | Cost per Hospitalization (All-cause admission) | American Hospital Network, 2016 Assume ~8% yearly increase |
| $17,600 | Cost to HME of NIV (AVAPS-AE (Trilogy 100)) acquisition | Philips Trilogy 100 MSRP |
| $14.74 | Cost to HME of NIV (AVAPS-AE (Trilogy 100)) repair Default value of $13.90 was obtained using the following formula: 10.5% of the devices require some type of repair/service (after year 2) * $132/avg repair cost per unit (inflated to 2018 values) | Philips-reported repair rates (obtained, 2018) |
| $1,036 | Cost to HME of NIV (AVAPS-AE (Trilogy 100)) supplies (annual) Filters, bacteria (22mm), single use 50-pack (MSRP $160.00) at 2 packs used per year = $320.00 per year; Disposable circuits (adult non-invasive passive, disposable, non-heated 10-pack) (MSRP $83.80) at 2 packs per year = $167.60 per year; NIV mask (MSRP $274) at 2 per year = $548.00. Annual TOTAL supplies costs = $320.00 + $167.60 + $548 = $1,035.60 | AVAPS-AE (Trilogy 100) Supplies MSRP (obtained, 2018) |
| $1,290 | Annual cost to HME of NIV (AVAPS-AE (Trilogy 100)) supportive care | • RT site visits ($75 per visit): 5 visits in first month; one visit per month for next 11 months • Phone call to patient ($15 per call): 5 min average plus 15 min for documentation; 6 calls per year • 1.5 hour for initial setup plus mileage and documentation |
1
Correction: A quality improvement initiative for COPD patients: A cost analysis
Facebook
Twitter
Linkedin
Whatsapp
